'Common' medication nonadherence in CV trials impacts outcomes, regardless of intervention
Two analyses of large randomized controlled trials suggest that participants not taking medications as prescribed may influence treatment effects and impact study findings, researchers reported.In analyses assessing medication nonadherence for the ISCHEMIA and MASTER DAPT trials, researchers found that the detrimental effect of nonadherence — worse health status — was consistent among